Advertisement

Topics

Locus Biosciences closes $19mm Series A

14:40 EST 14 Nov 2017 | Elsevier Business Intelligence

Locus Biosciences Inc. (developing a next-generation CRISPR-Cas platform for antimicrobials) raised $19mm in its Series A fin...

Original Article: Locus Biosciences closes $19mm Series A

NEXT ARTICLE

More From BioPortfolio on "Locus Biosciences closes $19mm Series A"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...